COVID-19 Immune Cell Products for Research

Everything You Need for Investigation of the COVID-19 Immune Response

Early indications are that the immune response to the novel coronavirus, SARS-CoV2, is not only important for a successful resistance to the virus, but also may be responsible for the most devastating pathology. We have the tools you need to investigate both of these extremes.

We have PBMC and plasma from individuals who have recovered from infection with SARS-CoV2. Some individuals experienced minimal symptoms, while others had significant illness. The history of their illness is included on the certificate of analysis along with HLA typing and antibody titers.

We also have a T cell line specific for a peptide from the spike protein of SARS-CoV2. These T cells kill cells that have been incubated with the peptide, but we do not yet know if they lyse virus infected cells or if they contribute to a cytokine storm.

Furthermore, we have vaccinated donor PBMCs, plasma, and serum samples (time series) provided in matched sets from heathy donors with no prior COVID-19 infection. Each set includes a sample prior to vaccination, after the first vaccine administration, and after the second vaccine administration (if applicable).

Future COVID-19 related products will be listed here as they become available.